Literature DB >> 33402401

Novel non-invasive particles in exhaled air method to explore the lining fluid of small airways-a European population-based cohort study.

Laith Hussain-Alkhateeb1, Björn Bake2, Mathias Holm1, Össur Emilsson3, Ekaterina Mirgorodskaya4, Anna-Carin Olin5.   

Abstract

INTRODUCTION: Respiratory tract lining fluid of small airways mainly consists of surfactant that can be investigated by collection of the particles of exhaled aerosol (PExA) method. This offers an exciting prospect to monitor small airway pathology, including subjects with asthma and smokers. AIM: To explore the influence of anthropometric factors and gender on phospholipids, surfactant protein A (SP-A) and albumin of the lining fluid of small airwaysand to examine the association with asthma and smoking. Furthermore, to examine if the surfactant components can predict lung function in terms of spirometry variables.
METHOD: This study employs the population-based cohort of the European Community Respiratory Health Survey III, including participants from Gothenburg city, Sweden (n=200). The PExA method enabled quantitative description and analytical analysis of phospholipids, SP-A and albumin of the lining fluid of small airways.
RESULTS: Age was a significant predictor of the phospholipids. The components PC14:0/16:0, PC16:0/18:2 (PC, phosphatidylcholine) and SP-A were higher among subjects with asthma, whereas albumin was lower. Among smokers, there were higher levels particularly of di-palmitoyl-di-phosphatidyl-choline compared with non-smokers. Most phospholipids significantly predicted the spirometry variables.
CONCLUSION: This non-invasive PExA method appears to have great potential to explore the role of lipids and proteins of surfactant in respiratory disease. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  asthma; exhaled airway markers; non invasive ventilation; tobacco and the lung

Year:  2021        PMID: 33402401      PMCID: PMC7786806          DOI: 10.1136/bmjresp-2020-000804

Source DB:  PubMed          Journal:  BMJ Open Respir Res        ISSN: 2052-4439


  21 in total

1.  Exhaled particles as markers of small airway inflammation in subjects with asthma.

Authors:  Per Larsson; Mona Lärstad; Björn Bake; Oscar Hammar; Anna Bredberg; Ann-Charlotte Almstrand; Ekaterina Mirgorodskaya; Anna-Carin Olin
Journal:  Clin Physiol Funct Imaging       Date:  2015-12-09       Impact factor: 2.273

2.  Effect of cholesterol on the molecular structure and transitions in a clinical-grade lung surfactant extract.

Authors:  Jenny Marie Andersson; Carl Grey; Marcus Larsson; Tiago Mendes Ferreira; Emma Sparr
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-17       Impact factor: 11.205

3.  Small airways in asthma: their independent contribution to the severity of hyperresponsiveness.

Authors:  Eef D Telenga; Maarten van den Berge; Nick H T Ten Hacken; Roland A Riemersma; Thys van der Molen; Dirkje S Postma
Journal:  Eur Respir J       Date:  2013-03       Impact factor: 16.671

4.  Consensus statement for inert gas washout measurement using multiple- and single- breath tests.

Authors:  Paul D Robinson; Philipp Latzin; Sylvia Verbanck; Graham L Hall; Alexander Horsley; Monika Gappa; Cindy Thamrin; Hubertus G M Arets; Paul Aurora; Susanne I Fuchs; Gregory G King; Sooky Lum; Kenneth Macleod; Manuel Paiva; Jane J Pillow; Sarath Ranganathan; Sarah Ranganathan; Felix Ratjen; Florian Singer; Samatha Sonnappa; Janet Stocks; Padmaja Subbarao; Bruce R Thompson; Per M Gustafsson
Journal:  Eur Respir J       Date:  2013-02-08       Impact factor: 16.671

5.  Exhaled Particles After a Standardized Breathing Maneuver.

Authors:  Björn Bake; Evert Ljungström; Annika Claesson; Hanne Krage Carlsen; Matthias Holm; Anna-Carin Olin
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-03-09       Impact factor: 2.849

Review 6.  Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease.

Authors:  Michael B Fessler; Ross S Summer
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

7.  Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma.

Authors:  E L Heeley; J M Hohlfeld; N Krug; A D Postle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-02       Impact factor: 5.464

8.  Airway monitoring by collection and mass spectrometric analysis of exhaled particles.

Authors:  Ann-Charlotte Almstrand; Evert Ljungström; Jukka Lausmaa; Björn Bake; Peter Sjövall; Anna-Carin Olin
Journal:  Anal Chem       Date:  2009-01-15       Impact factor: 6.986

9.  Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.

Authors:  Steffen Ohlmeier; Minna Vuolanto; Tuula Toljamo; Katri Vuopala; Kaisa Salmenkivi; Marjukka Myllärniemi; Vuokko L Kinnula
Journal:  J Proteome Res       Date:  2008-12       Impact factor: 4.466

10.  Intra-individual variation of particles in exhaled air and of the contents of Surfactant protein A and albumin.

Authors:  Spela Kokelj; Jeong-Lim Kim; Marianne Andersson; Gunilla Runström Eden; Björn Bake; Anna-Carin Olin
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

View more
  1 in total

1.  Current smoking alters phospholipid- and surfactant protein A levels in small airway lining fluid: An explorative study on exhaled breath.

Authors:  Emilia Viklund; Björn Bake; Laith Hussain-Alkhateeb; Hatice Koca Akdeva; Per Larsson; Anna-Carin Olin
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.